These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6303060)

  • 21. [A clinical and laboratory study of China-made cefotaxime].
    Niu WW; Wang QN; Lin YH
    Zhonghua Nei Ke Za Zhi; 1985 Nov; 24(11):641-5, 700. PubMed ID: 3833501
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibiotic therapy in pulmonary disease.
    Barsky P
    J Am Osteopath Assoc; 1973 Jan; 72(5):476-80. PubMed ID: 4486477
    [No Abstract]   [Full Text] [Related]  

  • 23. [Guaiacolglycolate of mepicycline in pneumology].
    Cascone A
    Minerva Med; 1970 Feb; 61(12):536-41. PubMed ID: 5417276
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experience with the use of a new cephalosporin (cefotaxime) in infectious bronchopulmonary pathology].
    Baldini EV; Bonucchi ME; Lodi SA; Rossi G
    G Ital Chemioter; 1980; 27(2):57-68. PubMed ID: 6281114
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ciprofloxacin in the treatment of respiratory infections. Analysis of an Italian series].
    Maggiolo F; Bianchi W; Ohnmeiss H
    G Ital Chemioter; 1988; 35(1-3):39-44. PubMed ID: 3256511
    [No Abstract]   [Full Text] [Related]  

  • 26. Doxycycline in the treatment of lower respiratory tract infections.
    Roy DC; Marwah SM; Rout BC; Mania R
    J Postgrad Med; 1980 Oct; 26(4):225-30. PubMed ID: 7230055
    [No Abstract]   [Full Text] [Related]  

  • 27. Study on the relationship between pharmacokinetics and antibacterial activity: comparison between ceftriaxone and cefotaxime within the respiratory tract.
    Fraschini F; Scaglione F
    Chemotherapy; 1989; 35(2):77-82. PubMed ID: 2758870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New therapeutic possibilities of amminosidin in pneumology (bacteriologic, physiopathologic and clinical observations)].
    Mariani B; Velluti G; Marchioni CF
    Atti Accad Med Lomb; 1973; 28(1-4):75-93. PubMed ID: 4807503
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ceftriaxone in septic processes].
    Torres A; Aguirre M; Ales JM
    Rev Clin Esp; 1983 Oct; 171(2):103-5. PubMed ID: 6318279
    [No Abstract]   [Full Text] [Related]  

  • 30. A study of cefotaxime versus netilmicin versus netilmicin and cefotaxime in serious infections.
    Sen RA; Keaney MG; Ganguli LA
    J Chemother; 1989 Jul; 1(4 Suppl):652-4. PubMed ID: 16312576
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical tolerance of kanendomycin in otorhinolaryngology].
    Barberi G
    G Ital Chemioter; 1977; 24(1-2):15-6. PubMed ID: 615757
    [No Abstract]   [Full Text] [Related]  

  • 32. [Kinetic and clinical studies on a new cephalosporin: Cefotiam].
    Soranzo ML; Capra E; Eandi M; Bosio G; Salassa B; Bendiscioli L; Bramato C; Musso E; Andreoni G; Morelli B; Fabiano A; Di Nola F; Misto P
    Minerva Med; 1982 Oct; 73(39):2671-8. PubMed ID: 6289193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical trial of the antibiotic Sisomycin].
    Mariani B; Mancini P
    G Ital Chemioter; 1977; 24(1-2):127-30. PubMed ID: 615756
    [No Abstract]   [Full Text] [Related]  

  • 34. Ceftriaxone: therapeutic results in various infections and kinetic studies.
    Giamarellou HJ; Tsagarakis J; Petrikkos G; Mavroudis K; Veldekis D; Daikos GK
    Arzneimittelforschung; 1984; 34(3):321-5. PubMed ID: 6329238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cefotaxime therapy for serious infections.
    Tanphaichitra D; Wanvarie S; Srimuang S
    J Med Assoc Thai; 1984 Feb; 67(2):108-10. PubMed ID: 6330259
    [No Abstract]   [Full Text] [Related]  

  • 36. [Monotherapy with cefotaxime in severe infections].
    Guerrero A; Pérez Gorricho B; Hellín T; Loza E; Bouza E
    Med Clin (Barc); 1984 Dec; 83(18):742-6. PubMed ID: 6097779
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacokinetic, bacteriological and clinical studies of cefotaxime in newborn and immature infants].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Nakajima T; Ishimoto K; Tominaga K; Yamashita F; Takajo N; Araki H; Imai S; Yuasa T; Tanaka Y; Tsugawa S; Nagayama K; Hashimoto T; Nakajima H; Matsuo H; Imuta F
    Jpn J Antibiot; 1982 Jul; 35(7):1819-45. PubMed ID: 6294363
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluation of cefotaxime in the treatment of infections in the newborn].
    Kobayashi Y; Haruta T; Okura K; Kuroki S; Fujiwara T; Goto K
    Jpn J Antibiot; 1982 Jul; 35(7):1801-15. PubMed ID: 6294361
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study on the use of cefotaxime in neonates].
    Iwai N; Sasaki A; Taneda Y; Mizoguchi F; Nakamura H
    Jpn J Antibiot; 1982 Jul; 35(7):1783-92. PubMed ID: 6294359
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of aztreonam in the treatment of acute and flare-ups of chronic infectious bronchopneumopathies].
    Aquino G; Barbera S; Romano F; Zottola V
    Clin Ter; 1988 Jan; 124(2):109-16. PubMed ID: 2973921
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.